Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
25.87
+1.36 (5.57%)
Sep 2, 2026, 12:35 PM EDT - Market open
Odyssey Therapeutics Employees
Odyssey Therapeutics had 100 employees as of June 30, 2026.
Employees
100
Change
n/a
Growth
n/a
Revenue / Employee
$990
Profits / Employee
-$1,600,270
Market Cap
1.24B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 100 | - | - |
| Mar 31, 2026 | 100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MannKind | 592 |
| MeiraGTx Holdings | 393 |
| Kura Oncology | 260 |
| Monte Rosa Therapeutics | 173 |
| Sana Biotechnology | 142 |
| MoonLake Immunotherapeutics | 130 |
| Alpha Tau Medical | 121 |
ODTX News
- 6 days ago - Odyssey Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 7 days ago - Odyssey Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 27 days ago - Evotec enters R&D collaboration with Odyssey Therapeutics - TheFly
- 27 days ago - Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - PRNewsWire
- 4 weeks ago - Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Odyssey Therapeutics Earnings release: Q2 2026 - Filings
- 4 weeks ago - Odyssey Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Odyssey Therapeutics Slides: Corporate presentation - Filings